Description
Tirzepatide is a novel “dual agonist” peptide that acts on both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. This synergistic action has made it a primary subject of study in metabolic research.
Research Mechanics Unlike single-receptor agonists, Tirzepatide engages two distinct incretin pathways. Research indicates this dual mechanism may offer enhanced efficacy in regulating metabolic markers compared to selective GLP-1 agonists alone.
Quality Control Our Tirzepatide is synthesized to the highest industry standards. Each batch acts as a reliable chemical standard for laboratory experimentation.
-
Appearance: White lyophilized powder
-
Solubility: Water soluble (Bacteriostatic Water recommended)
-
Storage: Store at -20°C for long-term stability.
FOR RESEARCH USE ONLY:
This product is sold strictly as a chemical reference standard for in-vitro laboratory research purposes only. It is not intended for human or animal consumption, injection, or administration of any kind. This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition. Bodily introduction into humans or animals is strictly prohibited. For use by qualified research professionals only.
